Current Problems in Pediatric and Adolescent Health Care
Volume 38, Issue 8 , Pages 241-261 , September 2008

Primary Care of Children and Adolescents with Down Syndrome: An Update

  • Rebecca A. Baum, MD

      Affiliations

    • Ohio State University, College of Medicine, Section of Developmental/Behavioral Pediatrics, Nationwide Children's Hospital, Columbus, Ohio
    • ,
  • Patricia L. Nash, MD

      Affiliations

    • Ohio State University, College of Medicine, Section of Developmental/Behavioral Pediatrics, Nationwide Children's Hospital, Columbus, Ohio
    • ,
  • Jessica E.A. Foster, MD

      Affiliations

    • Ohio State University, College of Medicine, Section of Developmental/Behavioral Pediatrics, Nationwide Children's Hospital, Columbus, Ohio
    • ,
  • Michelle Spader, Psy D

      Affiliations

    • The Ohio State University, College of Medicine, Section of Psychology, Nationwide Children's Hospital, Columbus, Ohio
    • ,
  • Karen Ratliff-Schaub, MD

      Affiliations

    • Ohio State University, College of Medicine, Section of Developmental/Behavioral Pediatrics, Nationwide Children's Hospital, Columbus, Ohio
    • ,
  • Daniel L. Coury, MD

      Affiliations

    • Ohio State University, College of Medicine, Section of Developmental/Behavioral Pediatrics, Nationwide Children's Hospital, Columbus, Ohio

References 

  1. Lejeune J, Gaustier M, Turpin R. A study of somatic chromosomes in nine infants with mongolism. Acad Sci Paris. 1959;240:1026–1027
  2. Peterson MB, Mikkelsen M. Nondisjunction in trisomy 21: origin and mechanisms. Cytogenet Cell Genet. 2000;91:199–203
  3. Canfield MA, Ramadhani TA, Yuskiv N, et al. Centers for Disease Control and Prevention. Improved national prevalence estimates for 18 selected major birth defects-United States, 1999-2001. MMWR Morb Mortal Wkly Rep. 2006;54:1301–1305
  4. Sherman SL, Freeman SB, Allen EG, Lamb NE. Risk factors for nondisjuntion of trisomy 21. Cytogenet Genome Res. 2005;111:273–280
  5. Capone GT. Down syndrome: advances in molecular biology and the neurosciences. J Dev Behav Pediatr. 2001;22:40–59
  6. American Academy of Pediatrics. Health supervision for children with Down syndrome. Pediatrics. 2001;107:442–449
  7. Cohen WI. Down syndrome: care of the child and family. In:  Levine MD,  Carey WB,  Crocker AC editor. Developmental–behavioral pediatrics. 3rd Edition. Philadelphia: W.B. Saunders; 1999;p. 240–248
  8. ACOG Practice Bulletin. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110:1459–1467
  9. Roizen NJ, Patterson D. Down's syndrome. Lancet. 2003;361:1281–1289
  10. Tolmie JL. Down syndrome and other autosomal trisomies. In:  Rimoin DL,  Connor JM,  Pyeritz RE,  Korf BR editor. Emery and Rimoin's principles and practice of medical genetics. 4th Edition. London: Churchill Livingstone; 2002;p. 1129–1183
  11. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005;353:2001–2011
  12. Warburton D, Dallaire L, Thangavelu M, Ross L, Levin B, Kline J. Trisomy recurrence: a reconsideration based on North American data. Am J Hum Genet. 2004;75:376–385
  13. Nussbaum RL, McInnes RR, Willard HF. Thompson and Thompson genetics in medicine (6th Revised Reprint Edition). Philadelphia: W.B. Saunders; 2004;
  14. ACOG Practice Bulletin. Screening for fetal chromosome abnormalities. Obstet Gynecol. 2007;109:217–227
  15. Wildschut HIJ, Peters TJ, Weiner CP. Screening in women's health, with emphasis on fetal Down's Syndrome, breast cancer, and csteoporosis. Hum Reprod Update. 2006;12:499–512
  16. Canick JA, MacRae AR. Second trimester serum markers. Semin Perinatol. 2005;29:203–208
  17. Reddy UM, Menutti MT. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institutes of Child Health and Human Developmental workshop. Obstet Gynecol. 2006;107:167–173
  18. Estroff JA. Prenatal diagnosis and imaging of genetic syndromes. Semin Roentgenol. 2004;39:323–335
  19. Mazza V, Pati M, Bertucci E, Re C, Ranzi A, Percesepe A, et al. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases. Prenat Diagn. 2007;27:180–183
  20. Olney RS, Moore CA, Khoury MJ, et al. Centers for Disease Control and Prevention. Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. MMWR Recomm Rep. 1995;44:1–12
  21. Olsen CL, Cross PK. Trends in the use of prenatal diagnosis in New York state and the impact of biochemical screening on the detection of Down Syndrome. Prenat Diagn. 1997;17:1113–1124
  22. Skotko B. Mothers of children with Down syndrome reflect on their postnatal support. Pediatrics. 2005;115:64–77
  23. Freeman S, Taft L, Dooley KJ. Population-based study of congenital heart defects in Down Syndrome. Am J Med Genet. 1998;80:213–217
  24. In:  Van Dyke DC,  Mattheis P,  Schoon Eberly S,  Williams J editor. Medical and surgical care for children with Down syndrome: A Guide for Parents. Baltimore: Woodbine House; 1995;
  25. Zachor DA, Mroczek-Musulman E, Brown P. Prevalence of celiac disease in Down syndrome in the United States. J Pediatr Gastroenterol Nutr. 2000;31:275–279
  26. Allison DB, Gomez JE, Heshka S. Decreased resting metabolic rate among persons with Down Syndrome. Int J Obes Relat Metab Disord. 1995;19:858–861
  27. Shott SR, Joseph A, Heithaus D. Hearing loss in children with Down syndrome. Int J Pediatr Otorhinolaryngol. 2001;61:199–205
  28. Sare Z, Ruvalcaba RH, Kelley VC. Prevalence of thyroid disorder in Down syndrome. Clin Genet. 1978;154–158
  29. Cohen WI. Health care guidelines for individuals with Down syndrome: 1999 revision. Down Syndr Q. 1999;4:1–16
  30. Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's Syndrome. Br J Haematol. 2000;110:512–524
  31. Rogers PT, Roizen NJ, Capone GT. Down syndrome. In:  Capute AJ,  Accardo PJ editor. Developmental disabilities in infancy and childhood. 2nd edition. Baltimore: Brookes Publishing; 1996;p. 221–244
  32. Pueschel SM, Scola FH. Atlantoaxial instability in individuals with Down Syndrome: epidemiologic, radiographic, and clinical studies. Pediatrics. 1987;80:555–560
  33. Myers BA, Pueschel SM. Psychiatric disorders in persons with Down Syndrome. J Nerv Ment Dis. 1991;179:609–613
  34. Rice C Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR CDC Surveill Summ. 2007;56:12–28
  35. Cohen WI, Patterson B. Neurodevelopmental disorders in Down syndrome. In:  Hassold TJ,  Patterson D editor. Down syndrome: a promising future, together. New York: Wiley-Liss; 1999;p. 45–51
  36. Dalton AJ, Crapper-McLachlan DR. Clinical expression of Alzheimer's disease in Down Syndrome. Psychiatr Clin North Am. 1986;9:659–670
  37. Sharav T, Bowman T. Dietary practices, physical activity, and body-mass index in a selected population of Down syndrome children and their siblings. Clin Pediatr (Phila). 1992;31:341–344
  38. Cronk C, Crocker AC, Pueschel SM, Shea AM, Zackai E, Pickens G, et al. Growth charts for children with Down Syndrome: 1 month to 18 years of age. Pediatrics. 1988;81:102–110
  39. Cronk CE, Chumlea WC, Roche AF. Assessment of overweight children with trisomy 21. Am J Ment Defic. 1985;89:433–436
  40. Styles ME, Cole TJ, Dennis J, Preece MA. New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland. Arch Dis Child. 2002;87:104–108
  41. Al Husain M. Growth charts for children with Down's syndrome in Saudi Arabia: birth to 5 years. Int J Clin Pract. 2003;57:170–174
  42. Melyn MA, White MA. Mental and developmental milestones of noninstitutionalized Down's syndrome children. Pediatrics. 1973;52:542–545
  43. Connolly BH, Morgan SB, Russell FF, Fulliton WL. A longitudinal study of children with Down syndrome who experienced early intervention programming. Phys Ther. 1993;73:170–179
  44. Libb JW, Myers GJ, Graham E, Bell B. Correlates of intelligence and adaptive behaviour in Down's syndrome. J Ment Defic Res. 1983;205–210
  45. Clements PR, Bates MV, Hafer M. Variability within Down's syndrome (trisomy-21): empirically observed sex differences in IQs. Ment Retard. 1976;14:30–31
  46. Mahoney G, Perales F, Wiggers B, Herman B. Responsive teaching: early intervention for children with Down syndrome and other disabilities. Downs Syndr Res Pract. 2006;11:18–28
  47. Carr J. Six weeks to twenty-one years old: a longitudinal study of children with Down's syndrome and their families. Third Jack Tizard memorial lecture. J Child Psychol Psychiatry. 1988;29:407–431
  48. Shepperdson B. Two longitudinal studies of the abilities of people with Down's syndrome. J Intellect Disabil Res. 1995;39:419–431
  49. Wishart JG. Development in children with Down syndrome: facts, findings, the future. Int J Disabil Dev Educ. 1998;45:343–363
  50. Silverman W. Down syndrome: cognitive phenotype. Ment Retard Dev Disabil Res Rev. 2007;13:228–236
  51. Chapman RS. Language and cognitive development in children and adolescents with Down syndrome. In:  Miller JF,  Leavitt LA,  Leddy M editor. Improving the communication of people with Down syndrome. Baltimore: Brookes Publishing; 1999;p. 99–110
  52. Wang PP. A neuropsychological profile of Down syndrome: cognitive skills and brain morphology. Ment Retard Dev Disabil Res Rev. 1996;2:102–108
  53. Fidler DJ, Nadel L. Education and children with Down syndrome: neuroscience, development, and intervention. Ment Retard Dev Disabil Res Rev. 2007;13:262–271
  54. Chapman RS, Hesketh LJ. Language, cognition, and short-term memory in individuals with Down syndrome. Downs Syndr Res Pract. 2001;7:1–7
  55. Kumin L. Speech intelligibility and childhood verbal apraxia in children with Down syndrome. Downs Syndr Res Pract. 2006;10:10–22
  56. Carlesimo GA, Marotta L, Vicari S. Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia. 1997;35:71–79
  57. Wang PP, Bellugi U. Evidence from two genetic syndromes for a dissociation between verbal and visual-spatial short-term memory. J Clin Exp Neuropsychol. 1994;16:317–322
  58. Vicari S, Verucci L, Carlesimo GA. Implicit memory is independent from IQ and age but not from etiology: evidence from Down and Williams syndromes. J Intellect Disabil Res. 2007;51:932–941
  59. Chapman RS. Language learning in Down syndrome: the speech and language profile compared to adolescents with cognitive impairment of unknown origin. Downs Syndr Res Pract. 2006;10:61–66
  60. Jarrold C, Baddeley AD, Phillips C. Long-term memory for verbal and visual information in Down syndrome and Williams syndrome: performance on the Doors and People test. Cortex. 2007;43:233–247
  61. Roizen NJ. Down syndrome. In:  Batshaw ML editors. Children with disabilities. 5th Edition. Baltimore: Brookes Publishing; 2002;p. 307–320
  62. Dykens EM, Shah B, Sagun J, Beck T, King BH. Maladaptive behaviour in children and adolescents with Down's syndrome. J Intellect Disabil Res. 2002;46:484–492
  63. Dykens EM, Kasari C. Maladaptive behavior in children with Prader-Willi syndrome (Down syndrome, and nonspecific mental retardation). Am J Men Retard. 1997;102:228–237
  64. Bhatia MS, Kabra M, Sapra S. Behavioral problems in children with Down syndrome. Indian Pediatr. 2005;42:675–680
  65. Cuskelly M, Dadds M. Behavioural problems in children with Down's syndrome and their siblings. J Child Psychol Psychiatry. 1992;33:749–761
  66. Coe DA, Matson JL, Russell DW, Slifer KJ, Capone GT, Baglio C, et al. Behavior problems of children with Down syndrome and life events. J Autism Dev Disord. 1999;29:149–156
  67. Fidler DJ, Barrett KC, Most DE. Age-related differences in smiling and personality in Down syndrome. J Dev Phys Disabil. 2005;17:263–280
  68. Sheridan R, Llerena JJ, Matkins S. Fertility in a male with Trisomy 21. J Med Genet. 1989;26:294–298
  69. Special Olympics: Coach > Coaching Guides > Basics of Special Olympics > Down Syndrome and Restrictions Based on Atlantoaxial Instability. Participation by Individuals with Down Syndrome Who have Atlantoaxial Instability. Washington DC. Special Olympics International. Available at: www.specialolympics.org/English/Coach/Coaching Guides/Basics of Special Olympics/Down Syndrome and restrictions based on atlantoaxial instability/Participation by individuals with Down syndrome who have atlantoaxial instability. Accessed August 5, 2008.
  70. Guralnick MJ. The effectiveness of early intervention for vulnerable children: a developmental perspective. Am J Men Retard. 1998;102:319–345
  71. U.S. Department of Education. Building the Legacy: IDEA 2004. Available at http://idea.ed.gov. Accessed August 5, 2008.
  72. Conlon CJ. Early intervention. In:  Batshaw ML editors. Children with disabilities. 5th Edition. Baltimore: Brookes Publishing; 2002;p. 579–588
  73. Roid GH. Stanford-Binet intelligence scales. 5th Edition. Rolling Meadows, IL: Riverside Publishing; 2003;
  74. Goldstein H, Schneider N, Thiemann K. Peer-mediated social communication intervention: when clinical expertise informs treatment development and evaluation. Top Lang Disord. 2007;27:182–199
  75. Buckley S, Bird G, Sacks B, Archer T. A comparison of mainstream and special education for teenagers with Down syndrome: implications for parents and teachers. Downs Syndr Res Pract. 2006;9:54–67
  76. Wishart J. Motivation and learning styles in young children with Down syndrome. Downs Syndr Res Pract. 2001;7:47–51
  77. Feeley KM, Jones EA. Addressing challenging behaviour in children with Down syndrome: the use of applied behaviour analysis for assessment and intervention. Downs Syndr Res Pract. 2006;11:64–77
  78. Fidler DJ, Most DE, Booth-LaForce C, Kelly JF. Temperament and behaviour problems in young children with Down syndrome at 12, 30, and 45 months. Downs Syndr Res Pract. 2006;10:23–29
  79. Prussing E, Sobo E, Walker E, Dennis K, Kurtin PS. Communication with pediatricians about complementary/alternative medicine: perspectives from parents of children with Down Syndrome. Ambul Pediatr. 2004;4:488–494
  80. Roizen N. Complementary and alternative therapies for Down syndrome. Ment Retard Dev Disabil Res Rev. 2005;11:149–155
  81. Adams SK. Complementary and alternative medicine: basic information and guidelines for use. Brown Univ Child Adolesc Behav Lett. 2008;24:1–7
  82. Salman MS. Systematic review of the effect of therapeutic dietary supplements and drugs on cognitive function in subjects with Down syndrome. Eur J Paediatr Neurol. 2002;6:213–219
  83. Van Dyke DC, Lang DJ, van Duyne S, Heide F, Change H. Cell therapy in children with Down syndrome: a retrospective study. Pediatrics. 1990;85:79–84
  84. Lobaugh NJ, Karaskov V, Rombough V, Rovet J, Bryson S, Greenbaum R, et al. Piracetam therapy does not enhance cognitive functioning in children with Down Syndrome. Arch Pediatr Adolesc Med. 2001;155:442–448
  85. Heller JH, Spiridigliozzi GA, Crissman BG, Sullivan JA, Eells RL, Li JS, et al. Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study. J Adol Psychopharmacol. 2006;16:755–765
  86. Prussing E, Sobo E, Walker E, Kurtin PS. Between ‘desperation' and disability rights: a narrative analysis of complementary/alternative medicine use by parents for children with Down syndrome. Soc Sci Med. 2005;60:587–598
  87. Jobling A, Cuskelly M. Young people with Down syndrome: a preliminary investigation of health knowledge and associated behaviors. J Intellect Dev Disabil. 2006;31:210–218
  88. Ouellette-Kuntz H. Understanding health disparities and inequities faced by individuals with Intellectual Disabilities. J Appl Res Intellect Disabil. 2005;18:113–121
  89. Sadovnick AD, Baird PA. Life expectancy. In:  Pueschel SM,  Pueschel JK editor. Biomedical concerns in persons with Down syndrome. Baltimore: Brookes Publishing; 1992;p. 47–57
  90. Hanson MJ. Twenty-five years after early intervention (A follow-up study of children with Down syndrome and their families). Infants Young Child. 2003;16:354–365
  91. Hattori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park H-S, et al. The DNA sequence of human chromosome 21. Nature. 2000;405:311–319
  92. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. Chromosome 21 and Down Syndrome: from genomics to pathophysiology. Nature. 2004;5:725–735
  93. Roubertoux PL, Kerdelhue BK. Trisomy 21: from chromosomes to mental retardation. Behav Genet. 2006;36:346–354

PII: S1538-5442(08)00066-7

doi: 10.1016/j.cppeds.2008.07.001

Current Problems in Pediatric and Adolescent Health Care
Volume 38, Issue 8 , Pages 241-261 , September 2008

Article Tools